Pain Management in nasogastric tube insertj. Medical procedure, unspecified, Insertion of gastric or duodenal sound
Conditions
Interventions
Intervention 1: Control group:
Nebulizing research syringe (1cc distilled water) plus 2cc distilled water
Then insertion of NG Tube in standard manner. Intervention 2: Intervention group:
Nebulizing r
Treatment - Drugs
Control group:
Nebulizing research syringe (1cc distilled water) plus 2cc distilled water
Then insertion of NG Tube in standard manner
Intervention group:
Nebulizing research syringe (1cc Ketamine =50 mg) plus 2cc distilled water
Then insertion of NG Tube in standard manner
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 149 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients admitted to emergency department of Imam Khomeini hospital which needs NG tube; Age greater than or equal to 15 years Exclusion Criteria: inability to express the pain(eg,Altered Mental Status,Language Barrier,Dementia, intoxication); Severe Hypertension (BP> 180/110); Unstable Multiple Trauma patients (SBP < 90mmhg, GCS<14, needs operating room at time of entrance); Pregnancy (visible or declared by patient); Use of Opium in last 6 hours; Opium addiction; Coronary Artery Disease (declared by patient); Decompensated Heart failure (Rales at lungs exam); Allergy to Ketamine; Reactive Airway Diseases; Abnormal Airway Anatomy ; Nasal fracture (in last week); deformity & bleeding; Patients who doesn't sign the consent form
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain of insertion of NG Tube. Timepoint: After insertion of tube. Method of measurement: Asking the patient.;Complications of insertion of nasogastric tube. Timepoint: continuously from insertion of tube until 60 min after procedure. Method of measurement: observation of complication such as: nausea, vomiting, nose bleed, hypoxia, tracheal insertion.;Complication of drug. Timepoint: continuously from begining of the nebulization of drug until 60 min after procedure. Method of measurement: Observation of Ketamine complication such as Hallucination, Nausea, vomiting, hypertension, agitation and seizure. | — |
Secondary
| Measure | Time frame |
|---|---|
| Arterial O2 Saturation. Timepoint: At the begining of the procedure until 30 min after that. Method of measurement: By pulse-oxymeter.;Heart Rate. Timepoint: At the begining of the procedure until 30 min after that. Method of measurement: By pulse-oxymeter.;Systolic BP. Timepoint: At the begining of the procedure until 30 min after that. Method of measurement: Sphygmomanometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Nejati M.D.
Tehran University of Medical Sciences
Outcome results
None listed